|  | 30-day mortality | Long-term mortality | ||
---|---|---|---|---|---|
Baseline parameters | SD | HR (95Â % CI) | P value | HR (95Â % CI) | P value |
Alkaline phosphatase, U/L | 68.9 | 1.23 (1.02–1.50) | 0.035 | 1.14 (0.95–1.38) | 0.16 |
Bilirubin total, mg/dl | 2.0 | 1.16 (1.02–1.32) | 0.028 | 1.15 (1.02–1.30) | 0.028 |
Aspartate transaminase, U/L | 303.5 | 1.08 (0.92–1.27) | 0.36 | 1.06 (0.91–1.23) | 0.45 |
Alanine transaminase, U/L | 192.0 | 1.07 (0.90–1.27) | 0.45 | 1.04 (0.90–1.21) | 0.60 |
AST/ALT ratio, n | 1.9 | 0.97 (0.78–1.21) | 0.81 | 0.95 (0.80–1.12) | 0.51 |
γ-Glutamyl transferase, U/L | 133.3 | 1.07 (0.87–1.32) | 0.54 | 1.10 (0.94–1.29) | 0.22 |
Albumin, g/L | 8.7 | 0.83 (0.68–1.01) | 0.06 | 0.86 (0.74–1.00) | 0.049 |
Normotest, % | 30.0 | 1.02 (0.82–1.26) | 0.87 | 1.06 (0.90–1.24) | 0.50 |